9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Eastern Cooperative Oncology Group
Roswell Park Cancer Institute
University of Southern California
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Tempus AI